XerostomiaNCT07847840
Effect of the Dietary Supplement to Alleviate Dry Mouth.
A study testing Dietary Supplement in people with Xerostomia, run by Lacer S.A. at 1 site in Spain.
Trial summary
The goal of this study is to learn if dietary supplement works to improve dry mouth in adults. The main question it aims to answer is: Does dietary supplement reduce dry mouth sensation in subjects with dry mouth? Participants will: Take dietary supplement every day for 7 days Visit the pharmacy at the beginning and… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Xerostomia
- What is being tested?
- Dietary Supplement
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 35 participants
- Where
- 1 siteSpain
- Study dates
- Oct 2026to Dec 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age ≥18 years.
- Presence of subjective xerostomia.
- Score ≥4 on the Numerical Rating Scale for Dryness (NRS, 0-10), established as the cut-off point for clinically relevant xerostomia.
- Result consistent with xerostomia on the Fox Questionnaire.
- Provision of written informed consent.
Who cannot join
- Inability to understand or complete the study questionnaires.
- Recent initiation of a specific treatment for xerostomia that may interfere with the evaluation.
- Presence of clinical conditions that, in the investigator's judgment, may interfere with the assessment of the study outcomes.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Spain1 site
Farmacia Marqueta
Barcelona
Garcia, 34 682319930, daniella@recerca.com
About this study
Official title: Prospective, Open-label Study to Evaluate the Effectiveness of Dietary Supplement for Dry Mouth in Relieving Xerostomia in the Community Pharmacy Setting.
The goal of this study is to learn if dietary supplement works to improve dry mouth in adults. The main question it aims to answer is:
- Does dietary supplement reduce dry mouth sensation in subjects with dry mouth?
Participants will:
- Take dietary supplement every day for 7 days
- Visit the pharmacy at the beginning and the end of the study
- Conditions
- Xerostomia
- Being tested
- Dietary Supplement
- Medical subject headings
- Xerostomia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Dietary SupplementDietary supplement
Dietary supplement will be taken daily for 7 days
| Study group | Role | What they receive |
|---|---|---|
| Dietary supplement | Experimental | Dietary supplement will be taken daily for 7 days Receives: Dietary Supplement: Dietary Supplement |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change from Baseline in the dry mouth intensity at 7 days
The dry mouth sensation will be evaluated by numeric dryness scale from 0 (no dryness) to 10 (maximum dryness imaginable).
Measured: From enrollment to the end of the study at 7 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Sep 2026
- Study startOct 2026 (estimated)
- Primary completionDec 2026 (estimated)
- Study completionDec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for XerostomiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 35 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Lacer S.A.
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07847840
- Sponsor's protocol ID
- LAC-XERO-01-26
- Status last verified
- Sep 2026
- First submitted
- 23 Sep 2026
- Last updated
- 29 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Only data included in the publication will be shared.
Study at a glance
From the registry record, last updated by the sponsor on 29 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prospective, Open-label Study to Evaluate the Effectiveness of Dietary Supplement for Dry Mouth in Relieving Xerostomia in the Community Pharmacy Setting.
- ClinicalTrials.gov ID
- NCT07847840
- Acronym / sponsor ID
- LAC-XERO-01-26
- Conditions
- Xerostomia
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 35 participants (estimated)
- Lead sponsor
- Lacer S.A.Industry (pharma, biotech, devices)
- Study start
- Oct 2026 (estimated)
- Primary completion
- Dec 2026 (estimated)
- Study completion
- Dec 2026 (estimated)
- First posted
- 29 Sep 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this study is to learn if dietary supplement works to improve dry mouth in adults. The main question it aims to answer is:
- Does dietary supplement reduce dry mouth sensation in subjects with dry mouth?
Participants will:
- Take dietary supplement every day for 7 days
- Visit the pharmacy at the beginning and the end of the study
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Dietary supplement | Experimental | Dietary Supplement: Dietary SupplementDietary supplement will be taken daily for 7 days |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Age ≥18 years.
- Presence of subjective xerostomia.
- Score ≥4 on the Numerical Rating Scale for Dryness (NRS, 0-10), established as the cut-off point for clinically relevant xerostomia.
- Result consistent with xerostomia on the Fox Questionnaire.
- Provision of written informed consent.
Key exclusion criteria (3 listed)
- Inability to understand or complete the study questionnaires.
- Recent initiation of a specific treatment for xerostomia that may interfere with the evaluation.
- Presence of clinical conditions that, in the investigator's judgment, may interfere with the assessment of the study outcomes.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Dietary SupplementDietary supplement will be taken daily for 7 days | Dietary supplement | Dietary supplement |
Primary outcome
Change from Baseline in the dry mouth intensity at 7 days
Time frame: From enrollment to the end of the study at 7 days
The dry mouth sensation will be evaluated by numeric dryness scale from 0 (no dryness) to 10 (maximum dryness imaginable).
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Sep 2026.
- Individual participant dataSharing planned: No. Only data included in the publication will be shared.
Related trials for Xerostomia
Not yet recruitingPhase 1
R-2487 in Patients With Sjogren's Syndrome (SjD)
Sjogren's Syndrome, Sjögren
RecruitingPhase 1
A Trial in Healthy Adult Participants and Adults With Autoimmune Diseases to Test How HBM7020 is Tolerated and How it Behaves in the Body
Rheumatoid Arthritis, Systemic Lupus Erythematosus
RecruitingObservational study
Pain Phenotyping of Rheumatic Diseases - An Observational Study
Rheumatic Diseases, Lupus Erythematosus, Systemic
RecruitingObservational study
The Pathogenesis and Natural History of Sjogren's Disease
Sjogren's Syndrome, Salivary Gland
Recruiting
Evaluation of the Prevalence, and Immunological Characteristics of Small Fiber Neuropathy in Patients With Primary Sjögren's Syndrome
Sjögren's Syndrome, Small Fiber Neuropathy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Dietary Supplement in people with Xerostomia, run by Lacer S.A. at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 29 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Garcia (34 682319930, daniella@recerca.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change from Baseline in the dry mouth intensity at 7 days (time frame: From enrollment to the end of the study at 7 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Sep 2026.